Chemours (CC) Misses Q4 EPS by 5c

Go back to Chemours (CC) Misses Q4 EPS by 5c

The Chemours Company Reports Fourth Quarter and Full Year 2015 Results

February 23, 2016 5:00 PM EST

WILMINGTON, Del., Feb. 23, 2016 /PRNewswire/ --

Fourth Quarter 2015 Highlights

Net sales of $1.4 billion Adjusted EBITDA of $132 million Free cash flow of $175 million led by working capital release of ~$399 million Adjusted Net Income of $5 million, or $0.03 per diluted share Net loss of $86 million, or $0.48 per diluted share, after restructuring costs of $88 million and interest expense of $53 million

Other Highlights

Announced $140 million Aniline sale to The Dow Chemical Company Reduced costs by $100 million in second half of 2015 through transformation initiatives Reached... More